GlaxoSmithKline

  • 23andMe Admits ‘Mining’ Your DNA Data Is Its Last Hope

    23andMe Admits ‘Mining’ Your DNA Data Is Its Last Hope

    23andMe is in a death spiral. Almost everyone who wants a DNA test already bought one, a nightmare data breach ruined the company’s reputation, and 23andMe’s stock is so close to worthless it might get kicked off the Nasdaq. CEO Anne Wojcicki is on a crisis tour, promising investors the company isn’t going out of…


  • Remarkable Drug Trial Ends With All 18 Patients Cancer-Free

    Remarkable Drug Trial Ends With All 18 Patients Cancer-Free

    A cancer treatment has shown astounding results in a small clinical trial. All of the treated patients, who had a specific form of mid-stage rectal cancer, have since experienced complete remission. Though the findings are based on a sample size of just 18 people, they could hold important implications for treating these particular cancers.